enVVeno Medical Corporation (NVNO)
NASDAQ
Closed
Oct 23, 2026
Day's Range
6.5552 wk Range
6.55Overview - NVNO - enVVeno Medical Corporation
Key Statistics
Valuation
Enterprise Value
-15.88M
P/E (Trailing)
-0.22
P/E (Forward)
-1.20
PEG Ratio
0.0041
Price / Book
0.24
EV / EBITDA
0.92
Profitability
Profit Margin
0.00%
Operating Margin
0.00%
Return on Assets
-36.67%
Return on Equity
-58.53%
Ownership
Shares Outstanding
655.52K
Float
590.41K
Short % of Shares Outstanding
1.96%
Held by Insiders
8.22%
Held by Institutions
15.95%
Price stats
Beta
1.29
50-Day Avg
9.72
200-Day Avg
10.56
Analyst Consensus
1 analysts
Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - NVNO - enVVeno Medical Corporation
Peers - NVNO - enVVeno Medical Corporation
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
- NVNONASDAQenVVeno Medical Corporation5.19MMarket Cap-261.71%52-week change-0.22P/E (Trailing)0.00%Profit Margin
- GEHCNASDAQGE HealthCare Technologies Inc.32.50BMarket Cap-9.66%52-week change16.43P/E (Trailing)9.33%Profit Margin
- DXCMNASDAQDexCom Inc.32.44BMarket Cap+18.88%52-week change34.14P/E (Trailing)20.11%Profit Margin
- PODDNASDAQInsulet Corporation9.78BMarket Cap-131.64%52-week change26.42P/E (Trailing)12.29%Profit Margin
- TLTLTNASDAQiShares 20+ Year Treasury Bond ETF9.46BMarket Cap-14.37%52-week change—P/E (Trailing)—Profit Margin
- BRKRNASDAQBruker Corp.8.77BMarket Cap+32.91%52-week change74.88P/E (Trailing)-2.03%Profit Margin
- LIVNNASDAQLivaNova PLC4.45BMarket Cap+32.91%52-week change23.93P/E (Trailing)12.81%Profit Margin
Profile Summary - NVNO - enVVeno Medical Corporation
About
enVVeno Medical Corporation is a medical device company focused on developing bioprosthetic, tissue-based solutions for venous disease. The company’s current portfolio centers on the VenoValve, a surgical replacement venous valve designed for patients with deep venous chronic venous insufficiency, and enVVe, a…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
